---
name: dermatology-workup
description: Diagnostic ladder (cytology→scraping→DTM→biopsy), pruritus scoring, common differentials by species (atopy, flea allergy, food allergy, Demodex, Sarcoptes, Malassezia), treatment tiers.
---

# Dermatology Workup

## Overview

Evidence-based diagnostic progression from non-invasive to invasive techniques. Includes pruritus quantification (VAS, CPAT), differential diagnosis by species, Malassezia management, and multimodal treatment strategies.

## When to Use

- User presents pruritic/alopecic dermatologic cases (dogs, cats, exotics)
- User needs diagnostic escalation guidance or differential diagnosis
- Keywords: pruritus, dermatitis, Demodex, Sarcoptes, atopy, FAD, food allergy, Malassezia, cytology, DTM, biopsy, seborrhea

## Diagnostic Ladder

**1. Cytology** (First-line, <24 hours)
- Acetate tape or swab, Diff-Quik staining; yields cocci, yeast, bacteria
- **Malassezia**: Peanut-shaped organisms; overgrowth suggests predisposition (atopy, otitis)
- Limitation: Cannot detect Demodex/Sarcoptes

**2. Skin Scraping** (Second-line)
- Deep scrape (until bleeding) for Demodex; superficial for Sarcoptes/Cheyletiella
- Sensitivity: Sarcoptes 50-70%, Demodex 70-80%; repeat if high suspicion
- Diagnostic threshold: >5 Demodex mites/low-power field

**3. Dermatophyte Test Medium (DTM)**
- Culture 2-3 weeks; Microsporum canis (most common) produces red/pink color
- Sensitivity 70-80%; negative result does not exclude ringworm
- Confirmatory: Sabouraud agar or MALDI-TOF for definitive species ID

**4. Skin Biopsy** (Definitive)
- 6-8 mm punch from active lesion margin; special stains (PAS, GMS) for fungi
- Indicated: Refractory cases, suspected autoimmune, chronic scaling, neoplasia
- Sample multiple sites increases diagnostic yield

## Pruritus Scoring

**Visual Analog Scale (VAS)**: 0-10 owner-reported (0 = none, 10 = severe); trending more important than absolute
**Canine Pruritus Assessment Tool (CPAT)**: Scratching bouts, biting frequency, sleep disruption, lesion severity
**Feline**: Grooming frequency, alopecia, self-trauma patterns

## Common Differentials by Species

### Dogs
1. **Atopic Dermatitis**: 10-15% prevalence; onset 1-3 years; face/ears/neck/paws; **diagnosis**: clinical (parasites/food/infection ruled out)
2. **Flea Allergy Dermatitis (FAD)**: Single flea triggers reaction; caudal dorsum, tail, rear limbs; **MANDATORY** flea prevention trial
3. **Food Allergy**: 8-12 week elimination diet (novel protein); year-round (non-seasonal); concurrent GI signs common
4. **Demodex canis**: Localized vs. generalized; indicator of immunosuppression; requires treatment + underlying disease investigation
5. **Sarcoptes scabiei**: 50-70% diagnostic sensitivity; severe pruritus disproportionate to lesions; trial therapy justified

### Cats
1. **Atopy**: Often presents as over-grooming/miliary dermatitis; self-trauma common; exclusion diagnosis
2. **FAD**: Miliary dermatitis pathognomonic; single flea sufficient; strict flea control mandatory
3. **Food Allergy**: 8-12 week elimination (novel protein); presents with pruritus or GI signs
4. **Demodex cati**: Rare; generalized mange uncommon; associated with FIV/FeLV/immunosuppression
5. **Sarcoptes**: Rare in cats; presumptive diagnosis often necessary

## Malassezia Considerations

**Epidemiology**: Lipophilic yeast; overgrowth pathogenic in atopy, seborrhea, otitis, maceration
**Predisposed breeds**: Basset hounds, Cocker spaniels, Poodles, Shih Tzus
**Diagnosis**: Cytology (Diff-Quik); culture not standard (normal flora)
**Treatment**: Address underlying cause (critical); topical miconazole/terbinafine 2-4 weeks; systemic fluconazole 5-10 mg/kg daily (dogs)

## Treatment Tiers

**Tier 1**: Environmental control (flea prevention all household animals), novel protein trial, bathing, humidity reduction
**Tier 2**: Topical azoles (Malassezia), antibacterial (chlorhexidine), antihistamines (cetirizine, hydroxyzine 10-30% efficacy)
**Tier 3**: Systemic corticosteroids (0.5-1 mg/kg BID initial, taper essential); cephalexin 22-33 mg/kg BID (pyoderma, 2-4 weeks)
**Tier 4**: Cyclosporine 5-10 mg/kg BID (dogs/cats, 4-6 week onset); oclacitinib (JAK inhibitor, 24-48 hour onset); lokivetmab (IL-31 antibody, canine-specific)
**Tier 5**: Specialist referral for IDST, allergen immunotherapy, advanced dermatopathology

## Key Species Differences

- **Dogs**: Corticosteroids effective but taper essential; JAK inhibitors preferred for rapid pruritus control; cyclosporine for long-term
- **Cats**: Diabetes risk with corticosteroids; cyclosporine/JAK inhibitors preferred; elimination diet often diagnostic for food allergy

## Limitations

- Negative skin scrape does not exclude parasitic disease (50-80% sensitivity); repeat or trial therapy justified
- Negative DTM does not exclude dermatophytosis; clinical judgment essential
- Atopy/FAD/food allergy remain clinical diagnoses (exclusion-based); no gold-standard test exists
- Underlying immunosuppression must be identified before treating secondary Demodex
- Referral to board-certified dermatologist recommended for refractory, chronic, or suspected autoimmune cases


---
Source attribution: OpenVet-Projects
Original project: https://github.com/OpenVet-Projects/VetClaw/blob/a989b1cbf93c703bb95974616c4285c5e2098b3f/skills/clinical/dermatology-workup/SKILL.md
License: MIT
License information: https://opensource.org/license/mit
Original upstream instructions; downloaded from Mega AI Hub.

## Upstream license notice

MIT License

Copyright (c) 2026 OpenVet AI (openvet.ai)

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.



# Mega AI Hub resource metadata

Creator / publisher: OpenVet-Projects
Original project: https://github.com/OpenVet-Projects/VetClaw/blob/a989b1cbf93c703bb95974616c4285c5e2098b3f/skills/clinical/dermatology-workup/SKILL.md
Attribution basis: Source repository record

Fields of work: Healthcare & Life Sciences
Roles: Clinical Research, Health Informatics, Medical Writer
Specialties: Specialty not specified
Tools: Tool not specified
Country applicability: Country not specified
Classification basis: Source catalog labels
Instruction SHA-256: 961b97ea08ca98e388002394f7bc45d025d8c98a18d6b79b7f3f63f83adfafda